Clinical Trial Update: Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease [Phase 4]

View source ↗

Summary

A postmarketing phase 4 trial evaluating vedolizumab in lactating women with active ulcerative colitis or Crohn's disease to assess milk exposure and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative, Crohn's Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-03-04